- Home
- BGNE vs YUMC Comparison
BGNE vs YUMC Comparison
Compare BGNE & YUMC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BGNE
- YUMC
- Stock Information
- Founded
- BGNE 2010
- YUMC 1987
- Country
- BGNE Cayman Islands
- YUMC China
- Employees
- BGNE N/A
- YUMC N/A
- Industry
- BGNE Biotechnology: Pharmaceutical Preparations
- YUMC Restaurants
- Sector
- BGNE Health Care
- YUMC Consumer Discretionary
- Exchange
- BGNE Nasdaq
- YUMC Nasdaq
- Market Cap
- BGNE 19.2B
- YUMC 18.7B
- IPO Year
- BGNE 2016
- YUMC N/A
- Fundamental
- Price
- BGNE $175.87
- YUMC $48.71
- Analyst Decision
- BGNE Buy
- YUMC Strong Buy
- Analyst Count
- BGNE 8
- YUMC 3
- Target Price
- BGNE $253.69
- YUMC $49.57
- AVG Volume (30 Days)
- BGNE 476.1K
- YUMC 2.2M
- Earning Date
- BGNE 11-12-2024
- YUMC 02-04-2025
- Dividend Yield
- BGNE N/A
- YUMC 1.31%
- EPS Growth
- BGNE N/A
- YUMC 21.64
- EPS
- BGNE N/A
- YUMC 2.25
- Revenue
- BGNE $3,351,304,621.00
- YUMC $11,201,000,000.00
- Revenue This Year
- BGNE $969.39
- YUMC $5.76
- Revenue Next Year
- BGNE $24.79
- YUMC $8.14
- P/E Ratio
- BGNE N/A
- YUMC $21.67
- Revenue Growth
- BGNE 50.22
- YUMC 5.94
- 52 Week Low
- BGNE $126.97
- YUMC $28.50
- 52 Week High
- BGNE $248.16
- YUMC $52.00
- Technical
- Relative Strength Index (RSI)
- BGNE 34.52
- YUMC 53.37
- Support Level
- BGNE $174.50
- YUMC $48.27
- Resistance Level
- BGNE $180.00
- YUMC $49.78
- Average True Range (ATR)
- BGNE 6.73
- YUMC 0.87
- MACD
- BGNE -2.17
- YUMC 0.01
- Stochastic Oscillator
- BGNE 3.24
- YUMC 49.26
About BGNE BeiGene Ltd.
Founded in 2010 in Beijing and having listed on the Hong Kong exchange in 2018, BeiGene is a commercial-stage biotechnology company with global sales. It focuses on oncology therapeutics and differentiates itself from other companies with a contract research organization-free, or CRO-free strategy. BeiGene runs global clinical trials with its own team. As of 2023, its core drug is Brukinsa, a small molecule drug for various blood cancers that makes up more than 50% of BeiGene's revenue.
About YUMC Yum China Holdings Inc.
With almost 13,000 units and USD 10 billion in systemwide sales in 2022, Yum China is the largest restaurant chain in China. It generates revenue through its own restaurants and franchise fees. Key concepts include KFC (9,094 units) and Pizza Hut (2,903), but the company's portfolio also includes other brands such as Little Sheep, East Dawning, Taco Bell, Huang Ji Huang, COFFii & Joy, and Lavazza (collectively representing about 950 units). Yum China is a trademark licensee of Yum Brands, paying 3% of total systemwide sales to the company it separated from in October 2016.